San Diego, CA, United States of America

Fabio Broccatelli

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabio Broccatelli. Retrieved from https://idiyas.com/inventor/fabio-broccatelli-ire85hye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Fabio Broccatelli in Cancer Treatment

Introduction

Fabio Broccatelli is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the inhibition of specific proteins that play a role in cancer progression.

Latest Patents

Fabio holds a patent for "Lactams as CBL-B inhibitors selective over C-CBL." This compound, represented by formula (I), is designed for treating cancers that are susceptible to the inhibition of Cbl-B. His innovative approach offers potential new avenues for cancer therapy.

Career Highlights

Fabio is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking research in the field of oncology.

Collaborations

Throughout his career, Fabio has collaborated with notable colleagues, including Malcolm Huestis and Michael John Lambrecht. These partnerships have enhanced his research and expanded the impact of his inventions.

Conclusion

Fabio Broccatelli's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…